APA (7th ed.) Citation

Galgani, I., Annaratone, M., Casula, D., Di Maro, G., Janssens, M., Tasciotti, A., . . . Arora, A. K. (2022). Safety and immunogenicity of three doses of non-typeable Haemophilus influenzae-Moraxella catarrhalis (NTHi-Mcat) vaccine when administered according to two different schedules: A phase 2, randomised, observer-blind study. Respiratory Research, 23(1), 1. https://doi.org/10.1186/s12931-022-02019-4

Chicago Style (17th ed.) Citation

Galgani, Ilaria, Margherita Annaratone, Daniela Casula, Gennaro Di Maro, Michel Janssens, Annaelisa Tasciotti, Tino Schwarz, Murdo Ferguson, and Ashwani Kumar Arora. "Safety and Immunogenicity of Three Doses of Non-typeable Haemophilus Influenzae-Moraxella Catarrhalis (NTHi-Mcat) Vaccine When Administered According to Two Different Schedules: A Phase 2, Randomised, Observer-blind Study." Respiratory Research 23, no. 1 (2022): 1. https://doi.org/10.1186/s12931-022-02019-4.

MLA (9th ed.) Citation

Galgani, Ilaria, et al. "Safety and Immunogenicity of Three Doses of Non-typeable Haemophilus Influenzae-Moraxella Catarrhalis (NTHi-Mcat) Vaccine When Administered According to Two Different Schedules: A Phase 2, Randomised, Observer-blind Study." Respiratory Research, vol. 23, no. 1, 2022, p. 1, https://doi.org/10.1186/s12931-022-02019-4.